Glucagon-like peptide-1 7-36: a physiological incretin in man
Direct Meds claims their customers experience a 10 percent average loss in body weight over six months, a six-inch average reduction in waist size, and that 92 percent of users achieve lasting weight loss
Results: nejm.org/doi/full/10.10 #ADA2023 Retatrutide, a TRIPLE agonist (GLP1, GIP, glucagon), just released phase 2 trial results demonstrating 25% weight loss in half of people with #obesity
Below this starting weight or if you have a history of restrictive dieting a safer and more sustainable goal is 46 lb in 14 days
This combination creates dangerous hypoglycemic episodes, especially when you consume alcohol without eating food
The most helpful recommendation for patients would be to work closely with their clinician on gradual dosing and making specific dietary and lifestyle adjustments, he says